Widely used:Recently Viewed
Clear All
$411 Mln
--
1.86
--
0.01
-46.4 %
--
--
--
-933086
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Absci Corp (ABSI)
| -9.29 | -13.41 | 28.28 | 195.35 | -32.56 | -- | -- |
|
BSE Sensex*
| 13.08 | -1.05 | 2.13 | 24.69 | 11.60 | 16.47 | 11.89 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
|
|---|---|---|
|
Absci Corp (ABSI)
| 100.00 | -74.39 |
|
S&P Small-Cap 600
| 13.89 | -17.42 |
|
BSE Sensex
| 18.74 | 4.44 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
$411.07 Mln
$3.25 Mln
$0.00 Mln
$161.75 Mln
$13.33 Mln
High
$1.11 - 6.72
113,556,000
NASDAQ: ABSI
Vancouver, WA
https://www.absci.com
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation... platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; and with AstraZeneca PLC for AI-driven drug discovery against an oncology target. The company was founded in 2011 and is headquartered in Vancouver, Washington. Address: 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683 Read more
The total asset value of Absci Corp (ABSI) stood at $ 281 Mln as on 30-Jun-24
The share price of Absci Corp (ABSI) is $3.81 (NASDAQ) as of 03-Oct-2024 16:00 EDT. Absci Corp (ABSI) has given a return of -32.56% in the last 3 years.
Absci Corp (ABSI) has a market capitalisation of $ 411 Mln as on 02-Oct-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Absci Corp (ABSI) is 1.86 times as on 02-Oct-2024, a 40% discount to its peers’ median range of 3.12 times.
Since, TTM earnings of Absci Corp (ABSI) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Absci Corp (ABSI) and enter the required number of quantities and click on buy to purchase the shares of Absci Corp (ABSI).
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; and with AstraZeneca PLC for AI-driven drug discovery against an oncology target. The company was founded in 2011 and is headquartered in Vancouver, Washington. Address: 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
The CEO & director of Mr. Sean McClain. is Absci Corp (ABSI), and CFO & Sr. VP is Mr. Sean McClain.
There is no promoter pledging in Absci Corp (ABSI).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
996
|
|
|
994
|
|
|
980
|
|
|
819
|
| Absci Corp (ABSI) | Ratios |
|---|---|
|
Return on equity(%)
|
-46.4
|
|
Operating margin(%)
|
-2959.66
|
|
Net Margin(%)
|
-2838.89
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Absci Corp (ABSI) was $0 Mln.
$0.01
